The recently passed federal defense budget for 2026 includes dedicated funding for the use of bioengineered blood vessels ...
BRISBANE, Calif. and EDEN PRAIRIE, Minn., April 05, 2023 (GLOBE NEWSWIRE) -- CareDx, Inc. (CDNA) and Miromatrix Medical Inc. (MIRO) -- today announced an exclusive partnership aimed at advancing the ...
SAN DIEGO--(BUSINESS WIRE)-- Trestle Biotherapeutics, Inc., today announced a research collaboration with Humacyte, Inc. (HUMA) (Nasdaq: HUMA), a commercial-stage biotechnology platform company ...
Humacyte, Inc. (Nasdaq: HUMA), a commercial-stage biotechnology platform company developing universally implantable, bioengineered human tissues at commercial scale, today announced that the recently ...
- Patients treated with Symvess were observed to have high levels of patency, 100% limb salvage, and zero cases of conduit infection - "Vascular complications of medical or surgical procedures aren't ...
An international team of researchers bioengineering human liver tissues uncovered previously unknown networks of genetic-molecular crosstalk that control the organ's developmental processes – greatly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results